Raymond Kolls

Mr. Kolls’ clients include many of the world’s top law firms, with whom he works closely to assemble expert teams in high-profile complex litigation and consulting matters. A former trial lawyer and medical device general counsel, Mr. Kolls’ work often includes the most complex matters currently being litigated, many at the intersection of litigation, healthcare, antitrust, and intellectual property. He also co-leads BRG’s Client Relationship Management function, which formulates policy and addresses operational issues relating to new business intake. He previously served as a Listing Qualifications Panel member on the NASDAQ Stock Market LLC.

Mr. Kolls has a unique and varied background as a consultant and lawyer. He has over thirty years of experience as a senior in-house legal and consulting firm executive and general counsel. An attorney by training, he started his career as a trial lawyer and, before entering consulting, served as the general counsel of US public companies in the heavily regulated life sciences industry. As a litigator, he has tried cases to verdict including submission of evidence by experts. As a general counsel, he has executed over $3.5 billion in mergers and acquisitions and other strategic transactions worldwide.

This experience allows Mr. Kolls to serve as a key member of BRG’s management team, sharing responsibility for client relations issues, new business intake, expert recruitment, and relevant policy formulation.

Mr. Kolls has significant healthcare experience, including government investigations and False Claims Act (FCA) litigation. He has extensive familiarity with litigation management, compliance (including anti-corruption), and the handling of corporate and internal investigations. He has led corporate legal departments and teams of external lawyers and consultants on numerous major projects. He started his career at the international law firm Morgan Lewis & Bockius, where he practiced labor and employment law for clients such as American Airlines and Major League Baseball.

Mr. Kolls’ select engagements include:

• Assembling and co-leading expert witness and consulting teams in complex and high-profile pharmaceutical, medical device, managed care, and provider industry litigations and investigations, including legal matters that by scale of claimed damages are among the largest ever litigated in US legal history.
• Consulting relating to defense strategy and expert teams for federal FCA cases alleging fraud and abuse arising from provider, laboratory, organ transplant, cardiac and other facilities, and clinical specialties.
• Coordinating expert teams in products liability, mass tort, wage and hour, and consumer class action matters involving issues of class certification defense, data analytics, and damages.
• Assembling and co-leading expert witnesses and consulting teams for parties involved in high-profile antitrust and competition cases involving private litigation and regulatory agency matters.
• Coordinating a consulting team’s activity on a complex securities litigation matter involving application of the short-swing profit rules to certain classes of derivative securities.

Mr. Kolls is a frequent speaker and author, most recently coauthoring “The Expert Perspective: Changes to FRE 702” (March 2024, ABA Litigation Section). He has spoken before the Network of Trial Law Firms on litigation management and alternative fee arrangements with consulting firms; before the International Association of Defense Counsel on risk management and conflict of interest concepts in the modern litigation consulting firm; and to the AdvaMed Legal Committee and the AdvaMed Northern California Legal and Compliance Roundtable. His presentation topics have included “Current Trends in Healthcare Regulatory Enforcement,” “Early Case Evaluation and Damages Analysis Utilizing Structured and Unstructured Data,” and “Federal Monitors Exercise Extensive Unregulated Power under Deferred Prosecution Agreements: Lessons from the Front.” He is the coauthor (with Heiko E. Burow) of “Basic Concepts and Issues: A Primer on Distribution and Sales Representative Agreements in the Medical Device and Durable Medical Equipment Industries” (Journal of Health Law 39:2, Spring 2006, American Health Lawyers Association).